Medication info
Telmisartan/Amlodipine/Rosuvastatin Tablets 80/5/10 mg

Telmisartan/Amlodipine/Rosuvastatin Tablets 80/5/10 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tabletRosuvastatin Calcium Micronized›10.4mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
An oval two-layer tablet consisting of a white layer and a light blue layer.
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201801983 · Approved 2018.05.10 · Insurance code 645405310

Summary

Main use
Treatment of hypertension and dyslipidemia, and inhibition of atherosclerosis progression and cardiovascular disease risk
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking telmisartan/amlodipine in combination with rosuvastatin as a single-ingredient product, they may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose of each individual component (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin, and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased up to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. In a drug interaction study of the active ingredients of this medicine, telmisartan/amlodipine 80/10 mg and rosuvastatin 20 mg, in the presence of telmisartan/amlodipine, rosuvastatin Cmax increased by approximately 2.1-fold and AUC increased by approximately 1.2-fold. Therefore, when administering this medicine, assess the potential risk due to the increase in rosuvastatin Cmax and monitor the patient closely.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and dyslipidemia, and inhibition of atherosclerosis progression and cardiovascular disease risk

  • Essential hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • primary dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol
  • smoking
  • family history of early coronary artery disease
View approved original text

This medication is used as a combination of telmisartan and amlodipine in cases where hypertension is not adequately controlled. Rosuvastatin helps treat hypercholesterolemia and dyslipidemia. Telmisartan/Amlodipine is effectively used to lower blood pressure in patients with essential hypertension. Rosuvastatin is utilized as an adjunct to dietary therapy for patients with primary and familial hypercholesterolemia, mixed hyperlipidemia, and abnormal beta-lipoproteinemia. It also helps to lower total cholesterol and LDL cholesterol levels, delaying the progression of atherosclerosis and reducing the risk of complications such as stroke, myocardial infarction, and revascularization procedures in high-risk patients. Therefore, this medication is very useful for treating patients with both hypertension and dyslipidemia and is used to decrease the risk of cardiovascular disease.

How to take

Adult dose

Take 1 tablet once daily with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking telmisartan/amlodipine in combination with rosuvastatin as a single-ingredient product, they may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose of each individual component (amlodipine or telmisartan) be adjusted. However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin, and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased up to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. In a drug interaction study of the active ingredients of this medicine, telmisartan/amlodipine 80/10 mg and rosuvastatin 20 mg, in the presence of telmisartan/amlodipine, rosuvastatin Cmax increased by approximately 2.1-fold and AUC increased by approximately 1.2-fold. Therefore, when administering this medicine, assess the potential risk due to the increase in rosuvastatin Cmax and monitor the patient closely.

Precautions

This medication can cause serious harm or death to the fetus and newborn if given to pregnant women, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to any component of this medication or similar drugs should not take it. In particular, patients with hereditary angioedema or a history of angioedema should not use this medication. Pregnant women, women of childbearing potential, and nursing mothers should not take this medication and should use appropriate contraception. Patients with severe liver dysfunction or bile excretion issues should not take this medication. Patients with severe renal impairment, severe aortic stenosis, patients in shock, and patients with myopathy should also not use this medication. Patients with diabetes or moderate to severe renal impairment should be cautious as certain components may pose risks when used together. Elderly patients, those with hypotension, patients with hyperkalemia, and those with mild liver dysfunction should take this medication cautiously, and dosage adjustments may be necessary. This medication can cause muscle-related side effects, such as myalgia, myopathy, and rhabdomyolysis, so patients should consult a doctor immediately if symptoms like muscle pain or weakness occur. Liver function issues may occur, so regular liver function tests should be conducted before and during treatment. This medication may interact with other drugs, so patients should inform healthcare providers about any other medications they are taking. Nursing women should not take this medication, and if unavoidable, breastfeeding should be discontinued. Safety and efficacy in pediatric patients have not been adequately verified, so it is not recommended for use in children. In the case of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, so immediate medical attention should be sought and appropriate treatment given. This medication should be kept out of reach of children and it is advisable not to transfer it to another container.

Side effects

  • Peripheral edema
  • dyspepsia
  • frequent bowel movements
  • diabetes
  • dizziness
  • dry vesicular sounds
  • urticaria
  • unstable angina
  • onychomycosis
  • lumbar spinal stenosis
Show 345 more
  • ear discharge
  • vertigo
  • chronic gastritis
  • various gastrointestinal disorders
  • hiatal hernia
  • dysuria
  • rhinitis
  • discomfort in the oropharynx
  • lung disease
  • unspecified intestinal disease
  • benign gastrointestinal neoplasms
  • hemorrhoids
  • skeletal pain
  • osteoporosis
  • sensory decrease
  • movement disorders
  • atherosclerosis
  • frequent urination
  • tinnitus
  • hearing loss
  • halitosis
  • fatty liver
  • upper respiratory tract infection
  • low back pain
  • sinusitis
  • diarrhea
  • pharyngitis
  • influenza-like symptoms
  • dyspepsia
  • myalgia
  • urinary tract infection
  • abdominal pain
  • headache
  • dizziness
  • pain
  • fatigue
  • cough
  • hypertension
  • chest pain
  • nausea
  • palpitations
  • dependent edema
  • angina
  • rapid pulse
  • leg edema
  • abnormal ECG
  • insomnia
  • drowsiness
  • migraine
  • sensory abnormalities
  • involuntary muscle contractions
  • sensory decrease
  • flatulence
  • constipation
  • gastritis
  • vomiting
  • dry mouth
  • hemorrhoids
  • gastroenteritis
  • enteritis
  • gastroesophageal reflux
  • toothache
  • nonspecific gastrointestinal disease
  • gout
  • hypercholesterolemia
  • anxiety
  • depression
  • irritability
  • infection
  • fungal infection
  • abscess
  • otitis media
  • asthma
  • bronchitis
  • rhinitis
  • dyspnea
  • epistaxis
  • dermatitis
  • rash
  • eczema
  • pruritus
  • vascular edema
  • polymorphic erythema
  • rash
  • erythematous rash
  • papular rash
  • frequent urination
  • cystitis
  • vascular disease
  • cerebrovascular disease
  • visual abnormalities
  • conjunctivitis
  • ear pain
  • vascular edema
  • allergic reaction
  • fever
  • leg pain
  • malaise
  • palpitations
  • dependent edema
  • angina
  • rapid pulse
  • leg edema
  • abnormal ECG
  • insomnia
  • drowsiness
  • migraine
  • sensory abnormalities
  • involuntary muscle contractions
  • sensory decrease
  • flatulence
  • constipation
  • gastritis
  • vomiting
  • dry mouth
  • hemorrhoids
  • gastroenteritis
  • enteritis
  • gastroesophageal reflux
  • toothache
  • nonspecific gastrointestinal disease
  • gout
  • hypercholesterolemia
  • anxiety
  • depression
  • irritability
  • infection
  • fungal infection
  • abscess
  • otitis media
  • asthma
  • bronchitis
  • rhinitis
  • dyspnea
  • epistaxis
  • dermatitis
  • rash
  • eczema
  • pruritus
  • vascular edema
  • polymorphic erythema
  • rash
  • erythematous rash
  • papular rash
  • frequent urination
  • cystitis
  • vascular disease
  • cerebrovascular disease
  • visual abnormalities
  • conjunctivitis
  • ear pain
  • headache
  • edema
  • dizziness
  • flushing
  • palpitations
  • arrhythmia
  • bradycardia
  • chest pain
  • peripheral ischemia
  • syncope
  • orthostatic hypotension
  • vasculitis
  • peripheral neuropathy
  • tremors
  • dizziness
  • appetite loss
  • constipation
  • dyspepsia
  • dysphagia
  • diarrhea
  • flatulence
  • pancreatitis
  • vomiting
  • gingival hyperplasia
  • allergic reaction
  • weakness
  • low back pain
  • burning sensation
  • malaise
  • pain
  • stiffness
  • weight gain
  • weight loss
  • arthralgia
  • arthrosis
  • muscle cramps
  • myalgia
  • erectile dysfunction
  • insomnia
  • irritability
  • depression
  • abnormal dreams
  • anxiety
  • depersonalization
  • dyspnea
  • epistaxis
  • vascular edema
  • polymorphic erythema
  • pruritus
  • rash
  • erythematous rash
  • papular rash
  • frequent urination
  • urination disorders
  • enuresis
  • dry mouth
  • increased sweating
  • hyperglycemia
  • thirst
  • leukopenia
  • purpura
  • thrombocytopenia
  • headache
  • dizziness
  • constipation
  • nausea
  • abdominal pain
  • pruritus
  • rash
  • urticaria
  • myalgia
  • myopathy
  • rhabdomyolysis
  • weakness
  • vascular edema
  • allergic reaction
  • fever
  • leg pain
  • malaise
  • palpitations
  • dependent edema
  • angina
  • rapid pulse
  • leg edema
  • abnormal ECG
  • insomnia
  • drowsiness
  • migraine
  • sensory abnormalities
  • involuntary muscle contractions
  • sensory decrease
  • flatulence
  • constipation
  • gastritis
  • vomiting
  • dry mouth
  • hemorrhoids
  • gastroenteritis
  • enteritis
  • gastroesophageal reflux
  • toothache
  • nonspecific gastrointestinal disease
  • gout
  • hypercholesterolemia
  • anxiety
  • depression
  • irritability
  • infection
  • fungal infection
  • abscess
  • otitis media
  • asthma
  • bronchitis
  • rhinitis
  • dyspnea
  • epistaxis
  • dermatitis
  • rash
  • eczema
  • pruritus
  • vascular edema
  • polymorphic erythema
  • rash
  • erythematous rash
  • papular rash
  • frequent urination
  • cystitis
  • vascular disease
  • cerebrovascular disease
  • visual abnormalities
  • conjunctivitis
  • ear pain
  • headache
  • edema
  • dizziness
  • flushing
  • palpitations
  • arrhythmia
  • bradycardia
  • chest pain
  • peripheral ischemia
  • syncope
  • orthostatic hypotension
  • vasculitis
  • peripheral neuropathy
  • tremors
  • dizziness
  • appetite loss
  • constipation
  • dyspepsia
  • dysphagia
  • diarrhea
  • flatulence
  • pancreatitis
  • vomiting
  • gingival hyperplasia
  • allergic reaction
  • weakness
  • low back pain
  • burning sensation
  • malaise
  • pain
  • stiffness
  • weight gain
  • weight loss
  • arthralgia
  • arthrosis
  • muscle cramps
  • myalgia
  • erectile dysfunction
  • insomnia
  • irritability
  • depression
  • abnormal dreams
  • anxiety
  • depersonalization
  • dyspnea
  • epistaxis
  • vascular edema
  • polymorphic erythema
  • pruritus
  • rash
  • erythematous rash
  • papular rash
  • frequent urination
  • urination disorders
  • enuresis
  • dry mouth
  • increased sweating
  • hyperglycemia
  • thirst
  • leukopenia
  • purpura
  • thrombocytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that can block light, at room temperature between 1 and 30 degrees Celsius. Storing it this way helps to maintain the medication's efficacy and prevent degradation.

Appearance and packaging

Appearance

An oval two-layer tablet consisting of a white layer and a light blue layer.

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.